As coronavirus deaths in the United States cross the 160,000 mark, a new poll shows that even with a safe and effective vaccine many Americans will still refuse to get the shot. According to a Gallup poll, if a vaccine approved by the Food and Drug Administration was provided free of charge, 35% of Americans said they would not get the vaccine, according to a poll. by Gallup. And the people who refuse the vaccine are more likely to be Republicans. While 81% of Democrats said they would get the vaccine if there was a free, FDA-approved vaccine, only 47% of Republicans said the same. Independent people stand between the two groups, with 59% saying they will accept the vaccine.
Acceptance of a viable vaccine is higher than average in the young and the elderly, with 76% of those aged 18-29 and 70% saying they will get the vaccine. The people in the middle seem most reluctant with 59% of people between the ages of 50 and 64 saying they will accept the vaccine.
While the number might be surprising considering how COVID-19 has affected everyday life around the world, it still seems to be up from a few months ago. At the end of May, another poll found that only about half of Americans would definitely be vaccinated. The poll from the Associated Press-NORC Center for Public Affairs Research found that while 49% of Americans said they would be vaccinated, 20% said they wouldn’t and 31% said they were unsure. .
In the midst of the global race for vaccines, experts have carefully noted that even with a vaccine, it is likely not a silver bullet against coronavirus. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said the coronavirus vaccine was “98% effective is not great”. In a question and answer session with Brown University School of Public Health, Fauci said that the vaccine should not be seen as a perfect solution but rather “as a tool to make a pandemic disappear. pandemic, which becomes something that’s well-controlled. “The FDA says it can approve a vaccine as long as it is at least 50% effective.
Readers like you make our work possible. Help us keep providing reports, comments, and critiques that you won’t find anywhere else.
Join Slate Plus